Ignite Creation Date:
2025-12-24 @ 1:40 PM
Ignite Modification Date:
2025-12-29 @ 8:39 PM
Study NCT ID:
NCT01838395
Status:
COMPLETED
Last Update Posted:
2024-09-19
First Post:
2013-04-14
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase IIa Study Evaluating Safety and Efficacy of BL-8040 in Relapsed/Refractory AML Patients
Sponsor:
BioLineRx, Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
BL-8040.01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None